心力衰竭与保存的喷射分数:炎症的作用
Hongyi Liu1, Ruth Magaye2, David M Kaye2
1Monash Alfred Baker Centre for Cardiovascular Research, School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, 3004, Australia; Heart Failure Research Group, Baker Heart and Diabetes Institute, Melbourne, Australia; Biomarker Discovery Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.
在全球范围内,心力衰竭与保留喷射分数 (HFpEF) 影响了数百万人. 这篇评论探讨了炎症.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭是一个日益严重的全球健康问题,影响全球超过6430万个人.
- HFpEF占所有心力衰竭病例的50%以上,患病率和死亡率不断增加.
- 虽然-葡萄糖共载体2抑制剂 (SGLT2i) 是有前途的,但对HFpEF的有效药理治疗仍然有限.
研究的目的:
- 审查目前对HFpEF病原学的理解,重点关注炎症的作用.
- 探索抗炎策略在管理HFpEF中的治疗潜力.
- 为弥补HFpEF有效药理疗法的差距.
主要方法:
- 对HFpEF病变发生现有证据的文献综述.
- 在HFpEF中分析心脏代谢并发症,炎症和RAAS激活之间的相互作用.
- 对HFpEF的现有和潜在抗炎疗法的检查.
主要成果:
- HFpEF的发病过程涉及复杂的相互作用,包括炎症和RAAS激活,从而导致心脏重塑和腹功能障碍.
- 传统的RAAS阻塞在HFpEF中显示出有限的有效性,这表明需要替代治疗点.
- 越来越多的证据支持炎症在HFpEF进展中的重要性,但抗炎疗法尚未得到充分探索.
结论:
- 炎症在HFpEF病原和心脏重塑中起着至关重要的作用.
- 针对炎症为HFpEF提供了一个有前途的治疗途径.
- 对抗炎症治疗的进一步研究对于解决HFpEF未满足的医疗需求至关重要.
更多相关视频
09:37Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
Published on: December 2, 2014
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
相关概念视频
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Inflammation
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure Drugs: Diuretics
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
